Researchers report progress in looking for signs of lung cancer in the blood.

CyPath® Lung unit sales in April increased nearly 300% compared to April 2025Increasing unit sales for CyPath® Lung continues first quarter 2026 trend of accelerating adoption and clinical ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced a significant ...

A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic patterns can reveal whether a tumor has already begun to spread through ...

bioAffinity Technologies, Inc. ( (BIAF)) has released its Q3 earnings. Here is a breakdown of the information bioAffinity Technologies, Inc. presented to its investors. bioAffinity Technologies, Inc.

Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be getting screened for ...

KIT TO DETERMINE POSSIBLE EXPOSURE. LUNG CANCER IS THE REASON WHY I GREW UP WITH NO GRANDPARENTS, SO IT’S KIND OF A PERSONAL CONNECTION TO ME. MIKE JONES DOESN’T WANT TO LOSE ANYONE ELSE. HE LOVES MY ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that WPS Government Health Administrators, ...

What are pulmonary function tests? Pulmonary function tests (PFTs) are tests of lung function. They are intended to evaluate and monitor chronic obstructive pulmonary disease (COPD). COPD is ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...